Therefore, substantial revenue opportunity for conventional disease-modifying antirheumaticdrugs (DMARDs) remains in early lines of therapy.
因此,在早期治疗中,常规抗风湿性关节炎疾病缓解用药还有很大市场。
2
Objective To investigate the incidence and possible reasons of patients with rheumatoid arthritis (RA) who stopped taking slow-acting antirheumaticdrugs (SAADs).